About Hospital Sao Marcos
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
1
Ferrer Internacional S.A.
1
Grupo de Investigacao do Cancro Digestivo
1
Millennium Pharmaceuticals, Inc.
1
Shire
1
Société des Produits Nestlé (SPN)
1
Clinical Trials at Hospital Sao Marcos
During the past decade, Hospital Sao Marcos conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
2005-07-01
2008-07-01
Unknown status
45
ICTUS Study: International Citicoline Trial on Acute Stroke
2006-10-01
2012-03-01
Terminated
2,298
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
2008-05-01
2017-06-17
Completed
487
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Sao Marcos" #1 sponsor was "Celgene" with 1 trials, followed by "Ferrer Internacional S.A." with 1 trials
sponsored, "Grupo de Investigacao do Cancro Digestivo" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Shire"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sao Marcos"
#1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital Sao Marcos
According to Clinical.Site data, the most researched conditions in "Hospital Sao Marcos" are
"Acute Stroke" (1 trials), "Breastfeeding Mothers" (1 trials), "Cerebral Infarction" (1 trials), "Colorectal Carcinoma" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Sao Marcos" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Sao Marcos
Most popular intervention types in "Hospital Sao Marcos" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Asacol" (1 trials), "Cetuximab" (1 trials), "Citicoline" (1 trials), "Cyclophosphamide 750 mg/m^2" (1 trials) and "Doxorubicin 50 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Sao Marcos
The vast majority of trials in "Hospital Sao Marcos" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Sao Marcos
Currently, there are NaN active trials in "Hospital Sao Marcos".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Sao Marcos,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Sao Marcos, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".